Fabio Cury Profile
Fabio Cury

@dr_cury

Followers
225
Following
335
Media
3
Statuses
49

Radiation Oncologist @cusm_muhc | Assistant Professor @mcgill |Father&Husband | Brown belt @gbmontreal #graciebarra | 🇨🇦🇧🇷 | Educator/Learner

Canada
Joined June 2009
Don't wanna be here? Send us removal request.
@piet_ost
Piet Ost
4 months
🔬 10-year HYPO-RT-PC trial update: UHF 📆2.5 weeks 7# = CF 📆8 weeks 39# ✅ Same survival & toxicity ➡️ UHF may be more efficient! #ESTRO25 #ProstateCancer
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
36
96
@DrAlisonAllan
Alison Allan, PhD
7 months
🇨🇦🇨🇦 Goosebumps. #ResearchMatters #EndIt
@MichaelBuble
Michael Bublé
7 months
The courage to start something and the continued courage to follow through. Everyone needs inspiration and so many have found that in Terry Fox and his incredible legacy. Truthfully this video made me cry. We all know someone whose lives have been touched by cancer and how we
0
2
14
@drviviantan
Vivian Tan MD
1 year
🔥Hot off the press @EurUrolOncol IROCK 🇨🇦🇦🇺🇺🇸🇩🇪🇯🇵 demonstrating #SABR ⚡️yields moderate long-term renal function decline, low dialysis rates even in patients with a solitary kidney #radonc https://t.co/hogLg40zkk Thankful for mentors @_ShankarSiva @DrAlexLouie @DrCorreaRO
Tweet media one
3
53
131
@Ramysaleh86
Ramy Saleh, MD, MSc
1 year
Medical Oncology #fellowship program is open again!! #GUtumors , #Sarcoma, #ClinicalTrials and others. Apply if interested, fellowships are paid! applications are open 🥼 at @McgillOncology
0
6
11
@dr_cury
Fabio Cury
2 years
In press
@gusviani
Gustavo
2 years
🎙️5-day RT preop courses result in ⬆️ LC, high R0 margins and acceptable complication rates in #sarcoma ‼️@OncoAlert @RadiotherapyOn1 @fabiomoraesmd @RadioOncologia @dr_cury 📌Meta analysis➡️9 studies: 786 👥, 5-day pre-op RT, median 30 Gy/ 5 fr 📊RESULTS - Local control (LC)
Tweet media one
Tweet media two
Tweet media three
0
2
6
@drviviantan
Vivian Tan MD
2 years
Tweet media one
2
4
42
@WesKassouf
Wes Kassouf
2 years
Canadian experience on 864 patients treated with #radiation based therapy for muscle invasive #bladdercancer. Results from real world experience among tertiary centres mirrors data from reported clinical trials.
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
We investigated outcomes for patients with muscle-invasive bladder cancer treated with curative-intent radiation therapy as an alternative to surgical removal of the bladder. The benefit of chemoth...
4
16
58
@WesKassouf
Wes Kassouf
3 years
Congrats @dr_rkool on a great talk showing benefits of whole pelvis radiation vs bladder only for #bladdercancer patients treated with #radiation …a rational approach to advocate treatment of pelvic lymph nodes to enhance cure, and similar to what is done with radical surgery
4
5
30
@WesKassouf
Wes Kassouf
3 years
We are hiring an assistant professor who will focus on #immunology and #bladdercancer @McGillDeptSurg @cusm_muhc @mcgillu strong and supportive academic environment in the wonderful city of @montreal please apply or RT https://t.co/vxeDDfHtMa
Tweet media one
Tweet media two
Tweet media three
0
16
22
@NicholasZaorsky
Nicholas Zaorsky, MD MS
3 years
Kidney cancer staging in one figure. #KidneyCancer @AJCCancer 8th ed
Tweet media one
3
81
253
@_ShankarSiva
Shankar Siva
3 years
Trimodality bladder preservation versus cystectomy for muscle invasive bladder cancer; matched cohort #ASTRO22 @OncoAlert. Dr J Efstathiou - outcomes similar for TMT versus cystectomy. 13% required salvage cystectomy, but did not impact survival. Hydronephrosis a bad player ☹️
Tweet media one
Tweet media two
Tweet media three
Tweet media four
6
88
216
@RadioOncologia
Andre G, MD, Rad Onc ⚽️ 🇮🇹 🇨🇦
3 years
Meta-analysis of elective pelvic nodal irradiation Final version just released! Congrats: @gusviani @dr_cury @fabiomoraesmd https://t.co/hgyRYasffZ
0
6
8
@fabiomoraesmd
Dr. Fabio Moraes
3 years
“Meta-analysis of elective pelvic nodal irradiation using moderate hypofractionation for high-risk prostate cancer” (MENHYP-ENI) https://t.co/KjXc7K3FE3 @RadioOncologia @gusviani @dr_cury
0
9
20
@CanUrolAssoc
Canadian Urological Association
3 years
Happening now! DAY 1 | CANADIAN BLADDER CANCER FORUM 22 Thank you to our speakers #CBForum22 If you want to join us tomorrow, register here: https://t.co/o35OvtB93X @pcvblack @kalasri3 @lalaniMD @CanImmun @siemensr @dr_cury
Tweet media one
1
1
10
@RadioOncologia
Andre G, MD, Rad Onc ⚽️ 🇮🇹 🇨🇦
4 years
Educação continuada em radioterapia. Aula hoje sobre câncer de bexiga com o Dr. Fabio Cury @dr_cury
Tweet media one
0
2
3
@WesKassouf
Wes Kassouf
4 years
Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy. https://t.co/68yZmKR4dx @dr_rkool
1
4
21
@DrToddLee
Todd C. Lee
4 years
Third dose received. Merci palais des congrès team for accommodating healthcare workers in the absence of a coordinated response in some hospitals.
7
6
74
@dr_cury
Fabio Cury
4 years
It was a pleasure to share the stage (or the screen) with old and new friends and talk about Sarcoma at the #semanaonco. @alegronchi - hoping to see you in person, in Brazil, soon.
@drmarcelosa
Marcelo Sá
4 years
Muito honrado de participar, como moderador, de mais um evento da @sbco_oficial O XV Congresso Brasileiro de Cirurgia Oncológica junto com a III Semana Brasileira de Oncologia. Excelente discussão sobre sarcomas de partes moles. #sarcoma #cirurgiaoncologica #sbco #cancertemcura
Tweet media one
0
1
8
@Thalcin
Thierry Alcindor, MD, MSc
4 years
In anticipation of #ctos2021, a group picture of ⁦@McgillSarcoma⁩: ⁦@SinzianaDumitra⁩ , ⁦@dr_cury⁩ , myself and a few Twitterless colleagues .
Tweet media one
0
2
32
@SprakerMDPhD
Matt Spraker
4 years
Updated UCLA pre-op extremity #sarcoma 30 Gy in 5 fractions continue to show excellent outcomes: min 2 years, 6.5% LR, 13% late RT tox, 26.7% major WC. They're teasing 25 Gy in 5 fractions with chemotherapy too 😃 When is it standard? @ShaunaRadOnc @CShahMD @DrChowdharyMD
7
11
46